BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 27131606)

  • 1. Systems pharmacology - Towards the modeling of network interactions.
    Danhof M
    Eur J Pharm Sci; 2016 Oct; 94():4-14. PubMed ID: 27131606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systems pharmacology to predict drug safety in drug development.
    Trame MN; Biliouris K; Lesko LJ; Mettetal JT
    Eur J Pharm Sci; 2016 Oct; 94():93-95. PubMed ID: 27251780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systems pharmacology in drug development and therapeutic use - A forthcoming paradigm shift.
    Kloft C; Trame MN; Ritter CA
    Eur J Pharm Sci; 2016 Oct; 94():1-3. PubMed ID: 27449395
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanism-based pharmacokinetic-pharmacodynamic modeling: biophase distribution, receptor theory, and dynamical systems analysis.
    Danhof M; de Jongh J; De Lange EC; Della Pasqua O; Ploeger BA; Voskuyl RA
    Annu Rev Pharmacol Toxicol; 2007; 47():357-400. PubMed ID: 17067280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting drug-drug interactions: application of physiologically based pharmacokinetic models under a systems biology approach.
    Yeo KR; Jamei M; Rostami-Hodjegan A
    Expert Rev Clin Pharmacol; 2013 Mar; 6(2):143-57. PubMed ID: 23473592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using quantitative systems pharmacology for novel drug discovery.
    Pérez-Nueno VI
    Expert Opin Drug Discov; 2015 Dec; 10(12):1315-31. PubMed ID: 26328768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future avenues for Alzheimer's disease detection and therapy: liquid biopsy, intracellular signaling modulation, systems pharmacology drug discovery.
    Hampel H; Vergallo A; Caraci F; Cuello AC; Lemercier P; Vellas B; Giudici KV; Baldacci F; Hänisch B; Haberkamp M; Broich K; Nisticò R; Emanuele E; Llavero F; Zugaza JL; Lucía A; Giacobini E; Lista S;
    Neuropharmacology; 2021 Mar; 185():108081. PubMed ID: 32407924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-generation model-based drug discovery and development: quantitative and systems pharmacology.
    Allerheiligen SR
    Clin Pharmacol Ther; 2010 Jul; 88(1):135-7. PubMed ID: 20531467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards patient stratification and treatment in the autoimmune disease lupus erythematosus using a systems pharmacology approach.
    Ruiz-Cerdá ML; Irurzun-Arana I; González-Garcia I; Hu C; Zhou H; Vermeulen A; Trocóniz IF; Gómez-Mantilla JD
    Eur J Pharm Sci; 2016 Oct; 94():46-58. PubMed ID: 27080094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of systems pharmacology in drug discovery.
    Cucurull-Sanchez L; Spink KG; Moschos SA
    Drug Discov Today; 2012 Jul; 17(13-14):665-70. PubMed ID: 22405899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of pharmacometrics and quantitative systems pharmacology to cancer therapy: The example of luminal a breast cancer.
    Fleisher B; Brown AN; Ait-Oudhia S
    Pharmacol Res; 2017 Oct; 124():20-33. PubMed ID: 28735000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropharmacology beyond reductionism - A likely prospect.
    Margineanu DG
    Biosystems; 2016 Mar; 141():1-9. PubMed ID: 26723231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systems biology and pharmacology.
    Berg JM; Rogers ME; Lyster PM
    Clin Pharmacol Ther; 2010 Jul; 88(1):17-9. PubMed ID: 20562889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systems pharmacology: bridging systems biology and pharmacokinetics-pharmacodynamics (PKPD) in drug discovery and development.
    van der Graaf PH; Benson N
    Pharm Res; 2011 Jul; 28(7):1460-4. PubMed ID: 21560018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative Systems Pharmacology: A Case for Disease Models.
    Musante CJ; Ramanujan S; Schmidt BJ; Ghobrial OG; Lu J; Heatherington AC
    Clin Pharmacol Ther; 2017 Jan; 101(1):24-27. PubMed ID: 27709613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systems pharmacology modeling: an approach to improving drug safety.
    Bai JP; Fontana RJ; Price ND; Sangar V
    Biopharm Drug Dispos; 2014 Jan; 35(1):1-14. PubMed ID: 24136298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research.
    Danhof M; de Lange EC; Della Pasqua OE; Ploeger BA; Voskuyl RA
    Trends Pharmacol Sci; 2008 Apr; 29(4):186-91. PubMed ID: 18353445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Providing data science support for systems pharmacology and its implications to drug discovery.
    Hart T; Xie L
    Expert Opin Drug Discov; 2016; 11(3):241-56. PubMed ID: 26689499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systems biology impact on antiepileptic drug discovery.
    Margineanu DG
    Epilepsy Res; 2012 Feb; 98(2-3):104-15. PubMed ID: 22055355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systems Pharmacology in Small Molecular Drug Discovery.
    Zhou W; Wang Y; Lu A; Zhang G
    Int J Mol Sci; 2016 Feb; 17(2):246. PubMed ID: 26901192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.